Long‐term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma
British Journal of Haematology | June 30, 2014 | Volume: 167 | Issue: 4 | Pages: 563-565
10.1111/bjh.13004
| PMID 24974945